I agree that this site is using cookies. You can find further informations here.
X
Quach, D. H.
615  results:
Search for persons X
?
1

Response adaptive salvage treatment with daratumumab–lenali..:

Lim, S. ; Reynolds, J. ; Quach, H....
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D-RD) ..:

Weisel, K. ; Kumar, S. ; Moreau, P....
HemaSphere.  7 (2023)  S2 - p. 14-15 , 2023
Link: https://doi.org/10.1097/..
 
?
3

P30 SINGLE COHORT RESULTS FROM MAJESTEC-2: TECLISTAMAB (TEC..:

Searle, E. ; Quach, H. ; Wong, S....
HemaSphere.  7 (2023)  S2 - p. 27-27 , 2023
Link: https://doi.org/10.1097/..
 
?
4

Response adaptive salvage with KTd and ASCT for functional ..:

Turner, R. ; Quach, H. ; Horvath, N....
British Journal of Haematology.  202 (2023)  3 - p. 530-538 , 2023
Link: https://doi.org/10.1111/..
 
?
5

OFF‐THE‐SHELF CD30.CAR‐MODIFIED EPSTEIN‐BARR VIRUS‐SPECIFIC..:

Ramos, C. A. ; Quach, D. H. ; Lulla, P. D....
Hematological Oncology.  41 (2023)  S2 - p. 83-85 , 2023
Link: https://doi.org/10.1002/..
 
?
6

P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION A..:

Lesokhin, A. M. ; Arnulf, B. ; Niesvizky, R....
HemaSphere.  6 (2022)  - p. 839-840 , 2022
Link: https://doi.org/10.1097/..
 
?
7

PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING TH..:

Delimpasi, S. ; Quach, H. ; Cavo, M....
HemaSphere.  6 (2022)  - p. 1906-1907 , 2022
Link: https://doi.org/10.1097/..
 
?
8

Numerical Prediction of Failure in Single Point Incremental..:

, In: The Minerals, Metals & Materials Series; NUMISHEET 2022,
Quach, H. ; Xiao, X. ; Kim, J. J.. - p. 115-121 , 2022
Link: https://doi.org/10.1007/..
 
?
9

611 A mutation-independent role of TMEM16A for airway cysti..:

Lee, J. ; Quach, H. ; Cho, A...
Journal of Cystic Fibrosis.  21 (2022)  - p. S339 , 2022
Link: https://doi.org/10.1016/..
 
?
10

A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN..:

Lesokhin, AM ; Arnulf, B ; Niesvizky, R...
Hematology, Transfusion and Cell Therapy.  44 (2022)  - p. S245-S246 , 2022
Link: https://doi.org/10.1016/..
 
?
11

P907: CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB (KDD) VS ..:

Quach, H. ; Leleu, X. ; Mateos, M.-V....
HemaSphere.  6 (2022)  - p. 798-799 , 2022
Link: https://doi.org/10.1097/..
 
?
12

P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN..:

Lasica, M. ; Spencer, A. ; Campbell, P....
HemaSphere.  6 (2022)  - p. 836-837 , 2022
Link: https://doi.org/10.1097/..
 
?
13

P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN ..:

Nooka, A. ; Lonial, S. ; Grosicki, S....
HemaSphere.  6 (2022)  - p. 829-830 , 2022
Link: https://doi.org/10.1097/..
 
?
14

P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY ..:

Quach, H. ; Parmar, G. ; Ocio, E. M....
HemaSphere.  6 (2022)  - p. 835-836 , 2022
Link: https://doi.org/10.1097/..
 
?
15

P1573: VARIATION IN USE OF IMMUNOGLOBULIN AND IMPACT ON SUR..:

Chai, K. L. ; Wellard, C. ; Aoki, N....
HemaSphere.  6 (2022)  - p. 1454-1455 , 2022
Link: https://doi.org/10.1097/..
 
1-15